{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T18:29:18Z","timestamp":1776709758204,"version":"3.51.2"},"reference-count":92,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_173132"],"award-info":[{"award-number":["310030_173132"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.celrep.2021.110061","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T17:12:03Z","timestamp":1638292323000},"page":"110061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Vectored antibody gene delivery restores host B and T\u00a0cell control of persistent viral infection"],"prefix":"10.1016","volume":"37","author":[{"given":"Yusuf I.","family":"Ertuna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedict","family":"Fallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Friederike","family":"Marx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirela","family":"Dimitrova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Lena","family":"Kastner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doron","family":"Merkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1594-3189","authenticated-orcid":false,"given":"Daniel D.","family":"Pinschewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2021.110061_bib1","doi-asserted-by":"crossref","first-page":"e01925-17","DOI":"10.1128\/JVI.01925-17","article-title":"Therapeutic Efficacy of Vectored PGT121 Gene Delivery in HIV-1-Infected Humanized Mice","volume":"92","author":"Badamchi-Zadeh","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.110061_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nature10660","article-title":"Antibody-based protection against HIV infection by vectored immunoprophylaxis","volume":"481","author":"Balazs","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110061_bib3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nbt.2618","article-title":"Broad protection against influenza infection by vectored immunoprophylaxis in mice","volume":"31","author":"Balazs","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.celrep.2021.110061_bib4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nm.3471","article-title":"Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission","volume":"20","author":"Balazs","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2021.110061_bib5","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T\u00a0cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110061_bib6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nature12744","article-title":"Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys","volume":"503","author":"Barouch","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110061_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nri2454","article-title":"The who, how and where of antigen presentation to B cells","volume":"9","author":"Batista","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2021.110061_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0166-0934(91)90018-U","article-title":"Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates","volume":"33","author":"Battegay","year":"1991","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.celrep.2021.110061_bib9","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1099\/vir.0.82428-0","article-title":"Contributions of the lymphocytic choriomeningitis virus glycoprotein and polymerase to strain-specific differences in murine liver pathogenicity","volume":"88","author":"Bergthaler","year":"2007","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.celrep.2021.110061_bib10","doi-asserted-by":"crossref","first-page":"e1000080","DOI":"10.1371\/journal.pbio.1000080","article-title":"Impaired antibody response causes persistence of prototypic T\u00a0cell-contained virus","volume":"7","author":"Bergthaler","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.celrep.2021.110061_bib36","series-title":"Paul\u2019s Fundamental Immunology","article-title":"Antigen-Antibody Interactions and Monoclonal Antibodies","author":"Berzofsky","year":"2003"},{"key":"10.1016\/j.celrep.2021.110061_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T\u00a0cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2021.110061_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0042-6822(84)90007-2","article-title":"Lymphocytic choriomeningitis virus. VIII. Reciprocal formation of pseudotypes with vesicular stomatitis virus","volume":"137","author":"Bruns","year":"1984","journal-title":"Virology"},{"key":"10.1016\/j.celrep.2021.110061_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0042-6822(83)90135-6","article-title":"Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization","volume":"130","author":"Bruns","year":"1983","journal-title":"Virology"},{"key":"10.1016\/j.celrep.2021.110061_bib14","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1172\/JCI121960","article-title":"Circulating and intrahepatic antiviral B cells are defective in hepatitis B","volume":"128","author":"Burton","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2021.110061_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.immuni.2012.08.002","article-title":"Regulation of humoral immunity by complement","volume":"37","author":"Carroll","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2021.110061_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1084\/jem.165.1.64","article-title":"IgG2a restriction of murine antibodies elicited by viral infections","volume":"165","author":"Coutelier","year":"1987","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2021.110061_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.immuni.2014.01.005","article-title":"Molecular and transcriptional basis of CD4+ T\u00a0cell dysfunction during chronic infection","volume":"40","author":"Crawford","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2021.110061_bib18","doi-asserted-by":"crossref","first-page":"254ra129","DOI":"10.1126\/scitranslmed.3009512","article-title":"Broadly neutralizing antibodies abrogate established hepatitis C virus infection","volume":"6","author":"de Jong","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2021.110061_bib19","doi-asserted-by":"crossref","first-page":"11650","DOI":"10.1128\/JVI.00955-07","article-title":"Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus","volume":"81","author":"Eschli","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.110061_bib20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1084\/jem.20101773","article-title":"Viral persistence redirects CD4 T\u00a0cell differentiation toward T follicular helper cells","volume":"208","author":"Fahey","year":"2011","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2021.110061_bib21","doi-asserted-by":"crossref","first-page":"eaah6817","DOI":"10.1126\/sciimmunol.aah6817","article-title":"Interferon-driven deletion of antiviral B cells at the onset of chronic infection","volume":"1","author":"Fallet","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2021.110061_bib22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.celrep.2019.12.023","article-title":"Chronic Viral Infection Promotes Efficient Germinal Center B Cell Responses","volume":"30","author":"Fallet","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2021.110061_bib91","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1073\/pnas.0600652103","article-title":"Recovery of an arenavirus entirely from RNA polymerase I\/II-driven cDNA","volume":"103","author":"Flatz","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.celrep.2021.110061_bib23","doi-asserted-by":"crossref","first-page":"e1005090","DOI":"10.1371\/journal.ppat.1005090","article-title":"AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing Activity","volume":"11","author":"Fuchs","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2021.110061_bib24","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1084\/jem.174.6.1425","article-title":"Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression","volume":"174","author":"Fung-Leung","year":"1991","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2021.110061_bib25","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1084\/jem.187.9.1383","article-title":"Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes","volume":"187","author":"Gallimore","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2021.110061_bib26","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/334676a0","article-title":"Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice","volume":"334","author":"Goodnow","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110061_bib27","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.1128\/JVI.79.10.6272-6280.2005","article-title":"Induction of long-term protective antiviral endogenous immune response by short neutralizing monoclonal antibody treatment","volume":"79","author":"Gros","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.110061_bib28","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.1128\/JVI.78.11.5983-5995.2004","article-title":"Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies","volume":"78","author":"Haigwood","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.110061_bib90","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1084\/jem.20051557","article-title":"Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread","volume":"203","author":"Hangartner","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.celrep.2021.110061_bib29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.1208421","article-title":"Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection","volume":"334","author":"Harker","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.110061_bib30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1084\/jem.61.4.563","article-title":"The precipitin reaction between type III pneumococcus polysaccharide and homologous antibody: III. A quantitative study and a theory of the reaction mechanism","volume":"61","author":"Heidelberger","year":"1935","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2021.110061_bib31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.vaccine.2009.10.040","article-title":"The use of immune complex vaccines to enhance antibody responses against neutralizing epitopes on HIV-1 envelope gp120","volume":"28","author":"Hioe","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2021.110061_bib32","doi-asserted-by":"crossref","first-page":"16538","DOI":"10.1073\/pnas.1315295110","article-title":"HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice","volume":"110","author":"Horwitz","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.110061_bib33","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1073\/pnas.1031671100","article-title":"Public versus personal serotypes of a viral quasispecies","volume":"100","author":"Hunziker","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.110061_bib34","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1128\/JVI.00557-16","article-title":"Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization","volume":"90","author":"Iseda","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.110061_bib35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.autrev.2014.10.018","article-title":"Antigen excess in modern immunoassays: to anticipate on the unexpected","volume":"14","author":"Jacobs","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.celrep.2021.110061_bib37","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S1074-7613(00)80277-0","article-title":"The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus","volume":"5","author":"Kalinke","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2021.110061_bib38","doi-asserted-by":"crossref","first-page":"143958","DOI":"10.1172\/jci.insight.143958","article-title":"Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention","volume":"6","author":"Kisalu","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.celrep.2021.110061_bib39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/37789","article-title":"A crucial role for B cells in neuroinvasive scrapie","volume":"390","author":"Klein","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110061_bib40","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1084\/jem.20141050","article-title":"Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants","volume":"211","author":"Klein","year":"2014","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2021.110061_bib41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110061_bib42","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1016\/j.vaccine.2013.09.010","article-title":"Elicitation of broadly reactive antibodies against glycan-modulated neutralizing V3 epitopes of HIV-1 by immune complex vaccines","volume":"31","author":"Kumar","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2021.110061_bib43","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-020-0911-7","article-title":"IgG-cleaving endopeptidase enables in\u00a0vivo gene therapy in the presence of anti-AAV neutralizing antibodies","volume":"26","author":"Leborgne","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2021.110061_bib44","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.1128\/JVI.76.17.8769-8775.2002","article-title":"Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer","volume":"76","author":"Lewis","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.110061_bib45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/hgtb.2013.131","article-title":"Absolute determination of single-stranded and self-complementary adeno-associated viral vector genome titers by droplet digital PCR","volume":"25","author":"Lock","year":"2014","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.celrep.2021.110061_bib46","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/mt.2015.191","article-title":"Host Anti-antibody Responses Following Adeno-associated Virus-mediated Delivery of Antibodies Against HIV and SIV in Rhesus Monkeys","volume":"24","author":"Martinez-Navio","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.celrep.2021.110061_bib47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.immuni.2019.02.005","article-title":"Adeno-Associated Virus Delivery of Anti-HIV Monoclonal Antibodies Can Drive Long-Term Virologic Suppression","volume":"50","author":"Martinez-Navio","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2021.110061_bib48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41586-018-0531-2","article-title":"Combination therapy with anti-HIV-1 antibodies maintains viral suppression","volume":"561","author":"Mendoza","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110061_bib49","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/362758a0","article-title":"Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T\u00a0cells","volume":"362","author":"Moskophidis","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110061_bib50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1099\/0022-1317-76-2-381","article-title":"Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus","volume":"76","author":"Moskophidis","year":"1995","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.celrep.2021.110061_bib51","doi-asserted-by":"crossref","first-page":"8623","DOI":"10.1073\/pnas.0809818106","article-title":"High antigen levels are the cause of T\u00a0cell exhaustion during chronic viral infection","volume":"106","author":"Mueller","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2021.110061_bib52","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nm.2233","article-title":"Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques","volume":"16","author":"Ng","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2021.110061_bib53","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41591-019-0747-1","article-title":"Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T\u00a0cell immunity","volume":"26","author":"Niessl","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2021.110061_bib54","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature21435","article-title":"Early antibody therapy can induce long-lasting immunity to SHIV","volume":"543","author":"Nishimura","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110061_bib55","doi-asserted-by":"crossref","first-page":"e20201214","DOI":"10.1084\/jem.20201214","article-title":"Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia","volume":"218","author":"Nishimura","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2021.110061_bib92","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1084\/jem.185.12.2043","article-title":"HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice","volume":"185","author":"Pascolo","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.celrep.2021.110061_bib56","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1126\/science.aaa2148","article-title":"Vaccine-elicited CD4 T\u00a0cells induce immunopathology after chronic LCMV infection","volume":"347","author":"Penaloza-MacMaster","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.110061_bib57","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A","article-title":"Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T\u00a0cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses","volume":"29","author":"P\u00e9rarnau","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2021.110061_bib58","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1084\/jem.156.1.79","article-title":"Lymphocytic choriomeningitis virus killer T\u00a0cells are lethal only in weakly disseminated murine infections","volume":"156","author":"Pfau","year":"1982","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2021.110061_bib59","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ni.1745","article-title":"Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation","volume":"10","author":"Phan","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2021.110061_bib60","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1172\/JCI200422374","article-title":"Kinetics of protective antibodies are determined by the viral surface antigen","volume":"114","author":"Pinschewer","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2021.110061_bib61","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/346629a0","article-title":"Viral escape by selection of cytotoxic T\u00a0cell-resistant virus variants in\u00a0vivo","volume":"346","author":"Pircher","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110061_bib62","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1016\/S2352-3018(19)30003-7","article-title":"Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial","volume":"6","author":"Priddy","year":"2019","journal-title":"Lancet HIV"},{"key":"10.1016\/j.celrep.2021.110061_bib63","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1089\/hum.2017.101","article-title":"Gene Transfer of ZMapp Antibodies Mediated by Recombinant Adeno-Associated Virus Protects Against Ebola Infections","volume":"29","author":"Robert","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.celrep.2021.110061_bib64","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1172\/JCI121957","article-title":"PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection","volume":"128","author":"Salimzadeh","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2021.110061_bib65","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1128\/JVI.00210-15","article-title":"Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian\/Human Immunodeficiency Virus Infection","volume":"89","author":"Saunders","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.110061_bib66","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.110061_bib67","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1126\/science.aaf0972","article-title":"HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1","volume":"352","author":"Schoofs","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.110061_bib68","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/eji.201847772","article-title":"Residual LCMV antigen in transiently CD4+ T\u00a0cell-depleted mice induces high levels of virus-specific antibodies but only limited B-cell memory","volume":"49","author":"Schweier","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2021.110061_bib69","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.4049\/jimmunol.162.8.4536","article-title":"In\u00a0vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody","volume":"162","author":"Seiler","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2021.110061_bib70","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature12746","article-title":"Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia","volume":"503","author":"Shingai","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2021.110061_bib71","doi-asserted-by":"crossref","first-page":"e1005276","DOI":"10.1371\/journal.ppat.1005276","article-title":"Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection","volume":"11","author":"Sommerstein","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2021.110061_bib72","first-page":"849844","article-title":"Chronic viral infection promotes early germinal center exit of B cells and impaired antibody development","author":"Staupe","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2021.110061_bib73","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nm1244","article-title":"Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies","volume":"11","author":"Trkola","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2021.110061_bib74","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1126\/science.1191047","article-title":"HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals","volume":"329","author":"Trono","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.110061_bib75","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/ni.2606","article-title":"T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion","volume":"14","author":"Utzschneider","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2021.110061_bib76","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.omtm.2019.06.002","article-title":"AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 Region","volume":"14","author":"van den Berg","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.celrep.2021.110061_bib77","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/clinchem\/46.2.283","article-title":"Evaluation of seven commercial ELISA kits compared with the C1q solid-phase binding RIA for detection of circulating immune complexes","volume":"46","author":"Van Hoeyveld","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.celrep.2021.110061_bib78","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/infdis\/jix644","article-title":"Intramuscular Adeno-Associated Virus-Mediated Expression of Monoclonal Antibodies Provides 100% Protection Against Ebola Virus Infection in Mice","volume":"217","author":"van Lieshout","year":"2018","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2021.110061_bib79","first-page":"1113","article-title":"Ueber Das Zustandekommen Der Diphtherie-Immunit\u00e4t Und Der Tetanus-Immunit\u00e4t Bei Thieren","volume":"49","author":"von Behring","year":"1890","journal-title":"Deutsch. Med. Woch."},{"key":"10.1016\/j.celrep.2021.110061_bib80","doi-asserted-by":"crossref","first-page":"e1007395","DOI":"10.1371\/journal.ppat.1007395","article-title":"Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge","volume":"14","author":"Welles","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2021.110061_bib81","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","article-title":"Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment","volume":"77","author":"Wherry","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.110061_bib82","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.immuni.2015.01.009","article-title":"Antibody effector functions mediated by Fc\u03b3-receptors are compromised during persistent viral infection","volume":"42","author":"Wieland","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2021.110061_bib83","first-page":"885","article-title":"The separation of different cell classes from lymphoid organs. VI. The effect of osmolarity of gradient media on the density distribution of cells","volume":"22","author":"Williams","year":"1972","journal-title":"Immunology"},{"key":"10.1016\/j.celrep.2021.110061_bib84","doi-asserted-by":"crossref","first-page":"14438","DOI":"10.1002\/anie.201909343","article-title":"Harnessing Evolution to Make Medicines (Nobel Lecture)","volume":"58","author":"Winter","year":"2019","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.celrep.2021.110061_bib85","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.celrep.2021.110061_bib86","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1038\/s41467-018-07492-4","article-title":"Single-cell RNA sequencing unveils an IL-10-producing helper subset that sustains humoral immunity during persistent infection","volume":"9","author":"Xin","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2021.110061_bib87","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.immuni.2015.01.005","article-title":"Suppression of Fc\u03b3-receptor-mediated antibody effector function during persistent viral infection","volume":"42","author":"Yamada","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2021.110061_bib88","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1128\/JVI.00145-09","article-title":"Polyfunctional CD4+ T-cell induction in neutralizing antibody-triggered control of simian immunodeficiency virus infection","volume":"83","author":"Yamamoto","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2021.110061_bib89","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","article-title":"Viral immune evasion due to persistence of activated T\u00a0cells without effector function","volume":"188","author":"Zajac","year":"1998","journal-title":"J.\u00a0Exp. Med."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124721015473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124721015473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:28:32Z","timestamp":1761910112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124721015473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":92,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2211124721015473"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2021.110061","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vectored antibody gene delivery restores host B and T\u00a0cell control of persistent viral infection","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2021.110061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"110061"}}